We've learned a lot from lymphocytic choriomeningitis virus—now the time has come to fight it
Key findings:
There are no vaccines or therapies available for lymphocytic choriomeningitis virus (LCMV) infection. This pathogen spreads easily and is extremely common in people worldwide.
Infection with LCMV can cause birth defects in developing fetuses, and severe illness and even death in the immuncompromised.
New findings from La Jolla Institute for Immunology (LJI) scientists show how an engineered antibody can target LCMV and neutralize the virus. They found this antibody has the potential to both prevent infection and treat an already established infection.
With this better understanding of LCMV's weak spots, scientists can move forward ...















